日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

持续雄激素剥夺疗法联合或不联合转移灶靶向治疗寡转移性前列腺癌：多中心 II 期随机 EXTEND 试验

期刊:
影响因子:
doi:10.1016/j.eururo.2025.07.006
Sherry, Alexander D; Siddiqui, Bilal A; Haymaker, Cara; Fellman, Bryan M; Medina-Rosales, Marina N; Bathala, Tharakeswara K; Wang, Shuqi; Liu, Suyu; Seo, Aaron; Hara, Kieko; Lu, Hsinyi; Troncoso, Patricia; Chun, Stephen G; Ha, Chul S; Mayo, Lauren L; Mok, Henry; Park, Ryan J; Chapin, Brian F; Phillips, Ryan M; Deek, Matthew P; Kovitz, Craig A; Aparicio, Ana; Zurita, Amado J; Pilie, Patrick G; Cohen, Lorenzo; Choi, Seungtaek L; Reuben, Alexandre; Tran, Phuoc T; Corn, Paul G; Subudhi, Sumit K; Tang, Chad
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups

淋巴瘤试验放射治疗靶区命名：国家临床试验网络小组的共识建议

期刊:Lancet Haematology
影响因子:17.7
doi:10.1016/S2352-3026(24)00276-X
Saifi, Omran; Pinnix, Chelsea C; Ballas, Leslie K; Kelsey, Chris R; Milgrom, Sarah A; Terezakis, Stephanie A; Figura, Nicholas B; Parikh, Rahul R; Grecula, John C; Flampouri, Stella; Ha, Chul S; Lo, Andrea C; Plastaras, John P; Hodgson, David C; Hoppe, Bradford S
淋巴瘤
发表日期：2024
文献求助 收藏

The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis

前列腺癌选择性淋巴结照射的成本：盆腔接受 0、45 或 54 Gy 照射的远期生活质量结果和剂量学分析

期刊:Clinical and Translational Radiation Oncology
影响因子:2.7
doi:10.1016/j.ctro.2022.06.008
Jensen, Garrett L; Jhavar, Sameer G; Ha, Chul S; Hammonds, Kendall P; Swanson, Gregory P
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma

局部黏膜相关淋巴组织（MALT）淋巴瘤放射治疗疗效和毒性的前瞻性试验

期刊:International Journal of Radiation Oncology Biology Physics
影响因子:6.5
doi:10.1016/j.ijrobp.2020.11.070
Fang, Penny; Gunther, Jillian R; Pinnix, Chelsea C; Dong, Wenli; Strati, Paolo; Nastoupil, Loretta J; Steiner, Raphael E; Ahmed, Sairah; Damron, Ethan P; Fowler, Nathan; Nair, Ranjit; Westin, Jason R; Neelapu, Sattva; Ha, Chul S; Dabaja, Bouthaina S
毒理研究
淋巴瘤
发表日期：2021
文献求助 收藏

A customizable aluminum compensator system for total body irradiation

用于全身照射的可定制铝制补偿器系统

期刊:Journal of Applied Clinical Medical Physics
影响因子:2.2
doi:10.1002/acm2.13393
Naessig, Madison; Hernandez, Soleil; Astorga, Nestor Rodrigo; McCulloch, James; Saenz, Daniel; Myers, Pamela; Rasmussen, Karl; Stathakis, Sotirios; Ha, Chul S; Papanikolaou, Niko; Ford, John; Kirby, Neil
发表日期：2021
文献求助 收藏

Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816

巩固性放射治疗对晚期霍奇金淋巴瘤的潜在影响：SWOG S0816 的二次分析

期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.1080/10428194.2020.1768388
Ha, Chul S; LeBlanc, Michael; Schöder, Heiko; Pinnix, Chelsea C; Bartlett, Nancy L; Evens, Andrew M; Hsi, Eric D; Rimsza, Lisa; Knopp, Michael V; Zhang, Jun; Leonard, John P; Kahl, Brad S; Li, Hongli; Smith, Sonali; Constine, Louis S; Friedberg, Jonathan W
淋巴瘤
发表日期：2020
文献求助 收藏

Clinical Outcomes of Spatially Fractionated GRID Radiotherapy in the Treatment of Bulky Tumors of the Head and Neck

空间分割网格放射疗法治疗头颈部巨大肿瘤的临床结果

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.4637
Choi, J Isabelle; Daniels, Janeen; Cohen, Dane; Li, Ying; Ha, Chul S; Eng, Tony Y
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Case report of prostate ductal adenocarcinoma presenting with hematuria

前列腺导管腺癌伴血尿病例报告

期刊:Urology Case Reports
影响因子:0.4
doi:10.1016/j.eucr.2018.05.013
Pawlowski, Jamie; Swanson, Gregory P; Mahalingam, Devalingam; Ha, Chul S
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Commissioning an Elekta Versa HD linear accelerator

调试 Elekta Versa HD 直线加速器

期刊:Journal of Applied Clinical Medical Physics
影响因子:2.2
doi:10.1120/jacmp.v17i1.5799
Narayanasamy, Ganesh; Saenz, Daniel; Cruz, Wilbert; Ha, Chul S; Papanikolaou, Niko; Stathakis, Sotirios
发表日期：2016
文献求助 收藏

ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II

ACR 适宜性标准® 霍奇金淋巴瘤-预后良好 I 期和 II 期

期刊:American Journal of Clinical Oncology-Cancer Clinical Trials
影响因子:1.8
doi:10.1097/COC.0000000000000331
Dhakal, Sughosh; Advani, Ranjana; Ballas, Leslie K; Dabaja, Bouthaina S; Flowers, Christopher R; Ha, Chul S; Hoppe, Bradford S; Mendenhall, Nancy P; Metzger, Monika L; Plastaras, John P; Roberts, Kenneth B; Shapiro, Ronald; Smith, Sonali M; Terezakis, Stephanie A; Winkfield, Karen M; Younes, Anas; Constine, Louis S
淋巴瘤
发表日期：2016
文献求助 收藏